ArticleFrontiers in nutrition2025
Non-sugar sweeteners and children: the current picture and controversies.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Warning Labels for Nonnutritive Sweeteners: A Randomized Controlled Trial with Chilean Parents.Current developments in nutrition · 2026Article
- Article
- Non-nutritive sweeteners and body weight in children with type 1 and type 2 diabetes: a critical narrative review of current evidence, methodological challenges, biological mechanisms, and clinical implications.Frontiers in nutrition · 2026Review
- Association of low-calorie sweetened product consumption and intakes of free sugar and dietary patterns in UK adults: a national study from 2008 to 2019.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global effort to reduce childhood obesity and type 2 diabetes has increased the use of non-sugar sweeteners (NSS) as alternatives to sugar. However, the long-term health effects of NSS in children remain debated, with inconsistent evidence supporting a precautionary approach. This perspective article critically reviews current knowledge, highlights research gaps, and questions the broader context of NSS usage. There is a general consensus that the use of NSS is inadvisable before age 3 and strongly discouraged for those up to age 5. Beyond this age, uncertainties persist, especially regarding the benefits and risks for children who are overweight, obese, or have diabetes. There is an urgent need for robust, long-term studies on NSS exposure in children. Current regulatory measures such as varied labelling, school restrictions, and taxation reflect the lack of a unified scientific consensus and harmonised policies. To effectively protect children's health, it is essential to establish a global agreement and develop evidence-based guidelines on the use of NSS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.